Kyle Tan serves as the Chief Product & Business Development Officer at NOVI Health, leading the creation of technology-enhanced solutions for individuals with metabolic diseases since January 2019. In addition to this role, Kyle holds the position of Adjunct Assistant Professor at the Saw Swee Hock School of Public Health, National University of Singapore, starting in December 2017. Previously, Kyle was Deputy Head and Consultant in Preventive Medicine at the National University Health System, where leadership of teams focused on population health strategy and health data analytics occurred. Kyle also has experience as Acting Head of Intermediate and Long Term Care at the same institution and has held previous roles in clinical services, health policy planning, biodefense strategy, and primary care. Educational qualifications include a Master's in Public Health and an M.B.B.S. in Medicine, both from the National University of Singapore.